The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback